Neuroimaging, Part II

Joseph C. Masdeu, MD, PhD holds the Graham Family Distinguished Endowed Chair in Neurological Sciences at the Houston Methodist Institute of Academic Medicine and leads the Nantz National Alzheimer Center and Neuroimaging at the Houston Methodist Neurological and Research Institutes. He is Professor of Neurology at Weill Cornell Medical College. Dr. Masdeu is interested in the application of neuroimaging tools, including new molecular neuroimaging markers, to the study of neurodegenerative brain disorders. By clarifying disease mechanisms and providing quantifiable markers of disease progression, this research will lead to the production of new medications and greatly facilitate the testing of new therapies in smaller and better characterized patient samples. A native of Spain, where he became certified in Psychiatry after his MD degree at the University of Madrid, Dr. Masdeu is a US citizen who completed residency training in Chicago and was certified in Neurology by the American Board of Neurology and Psychiatry in 1976. He was a fellow in Neuropathology at the Brigham and Women’s Hospital of Harvard Medical School in 1976-77. In the 1980s, at the Albert Einstein College of Medicine, in New York, he directed the Alzheimer research component of a Program Project on Aging and Dementia. From 1991-2000 he was the Chairman of Neurology at the New York Medical College. He was Professor of Neurology and Director of Neurosciences at the University of Navarra Medical School, in Pamplona, Spain, from 2000-2008 and a Senior Staff Physician and Scientist at the Section of Integrative Neuroimaging of the Clinical Brain Disorders Branch of the Intramural Research Program of the National Institutes of Health (NIMH) from 2008-2014. He is the author of 142 peer-reviewed papers, 61 book chapters, and of seven books, including “Localization in Clinical Neurology,” now in its 6th edition. With a longstanding interest in neuroimaging, he is chairman of the Neuroimaging Research Group of the World Federation of Neurology. He has been a director of the American Academy of Neurology and president of the American Society of Neuroimaging. Since 2007 he is the Editor-in-Chief of the Journal of Neuroimaging. Dr. R. Gilberto González is Chief of Neuroradiology at the Massachusetts General Hospital and Professor of Radiology at the Harvard Medical School. He received his MD from Harvard Medical School and a PhD in biophysical chemistry from the University of California at Santa Cruz. He did post doctoral work in molecular biophysics at the Francis Bitter National Magnet Lab at MIT. His clinical training included an internship in medicine and a residency in radiology at the Brigham and Women's Hospital in Boston, and a neuroradiology fellowship at the MGH. He has published over 200 original, peer-reviewed scientific papers, over 100 chapters and reviews, and 3 books. He has published in the areas of ischemic stroke, brain tumors, cerebral hemorrhage, AIDS dementia and Alzheimer's disease, and has received research funding from the NIH, foundations and medical enterprises. He has given over 150 invited lectures at universities and at scientific meetings in the US, Europe, Latin America and Asia. He has received several honors including the Outstanding Researcher Award from the American Society of Neuroradiology, and has given the Taveras (Harvard), Newton (UCSF) and Wood (UNC) Lectures. He has reviewed grant applications as a member of NIH study sections and for several scientific organizations. Dr. González has been on the editorial board of the American Journal of Neuroradiology and Neurosurgery and is an ad hoc reviewer for many journals including the New England Journal of Medicine, The Lancet, Radiology and Stroke. He lives in Cambridge with his wife Michele, an atmospheric chemist, and their 2 daughters Susan and Ana.

Section III Spinal Diseases32. Functional anatomy of the spine33. Neuroimaging of spine tumors34. Vascular disease of the spine35. Infection36. Non-infectious inflammatory disorders37. Imaging of trauma of the spine 38. Metabolic and hereditary myelopathies39. Degenerative spine diseaseSection IV Diseases of the Peripheral Nervous System40. Peripheral Nerves41. Muscle: MRI42. Muscle: UltrasoundSection V Neurological Syndromes of the Adult: When and How to Image 43 Sudden Neurological Deficit44.Pituitary imaging45. Visual Impairment46. Vertigo and Hearing Loss47. Progressive Weakness or Numbness of Central or Peripheral Origin48. Gait and balance disorders49. Movement Disorders50. Cognitive or Behavioral Impairment51. Epilepsy52. Myelopathy53. Low Back Pain, RadiculopathySection VI Differential Diagnosis of Imaging Findings54. Structural Imaging of the Brain: MRI, CT55. Vascular Imaging: ultrasound56. Diffusion tensor imaging and functional MRISection VII Pediatric Neuroimaging 57. Normal development58. Congenital anomalies of the brain and spine59. Tumors60. Vascular disease61. Infections62. Trauma63. Metabolic, endocrine and other genetic disorders64. Cerebrospinal fluid circulation disorders65. Indications for the performance of neuroimaging in childrenSection VIII Interventional Neuroimaging66. Endovascular Treatment of Acute Ischemic Stroke67. Endovascular treatment of Intracranial Aneurysms68. Endovascular treatment of vascular malformationsSection IX Neuropathology and Experimental Models69. Postmortem imaging and neuropathologic correlations with imaging